Thư viện tri thức trực tuyến
Kho tài liệu với 50,000+ tài liệu học thuật
© 2023 Siêu thị PDF - Kho tài liệu học thuật hàng đầu Việt Nam

Tài liệu Báo cáo khoa học: Pyruvate reduces DNA damage during hypoxia and after reoxygenation in
Nội dung xem thử
Mô tả chi tiết
Pyruvate reduces DNA damage during hypoxia and after
reoxygenation in hepatocellular carcinoma cells
3Emilie Roudier*, Christine Bachelet and Anne Perrin
Unite´ de Biophysique Cellulaire et Mole´ culaire, IFR ‘RMN biome´dicale: de la cellule a` l’homme’, CRSSA, BP 87, La Tronche, France
Pyruvate, as well as lactate, is an end-product of glycolysis. Its production is enhanced in tumor cells,
where high rates of aerobic glycolysis, historically
known as the Warburg effect, are observed [1]. It is
only lately that pyruvate has been described as playing
an important role in cancer progression. First of all,
alterations in components of pyruvate metabolism
have been reported in tumor cells, and appeared to
increase cancer cell proliferation [2,3]. Moreover,
recent evidence supports a novel role of pyruvate in
metabolic signaling in tumors. Pyruvate has been
reported to promote hypoxia-inducible factor (HIF-1)
stability and activate HIF-1-inducible gene expression.
This can promote the malignant transformation and
survival of cancer cells [4,5]. Pyruvate also exhibits
strong angiogenic activity in vitro and in vivo and
positively affects angiogenic processes [6]. As the
angiogenic switch is a crucial event in tumorigenesis,
pyruvate may be important for cancer progression. All
together, these findings suggest that pyruvate could
induce the molecular signaling usually caused by
hypoxia.
Chronic or transient hypoxia in the tumor is induced
by heterogeneous bloodflow resulting from impaired
vascularization [7]. Tumor cells are often exposed to
shorter or longer periods of hypoxia or ischemia followed by reoxygenation or recirculation. An adaptive
response of cancer cells takes place through multifaceted changes [8], which are mainly coordinated by
HIF-1 [9]. The outcome is clonal selection of the
tumor cells that are most resistant and well adapted to
hypoxia [10]. Many alterations occur that induce
Keywords
DNA damage; glutathione; hypoxia;
pyruvate; reoxygenation
Correspondence
A. Perrin, CRSSA ⁄ RBP, Unite´ de
biophysique cellulaire et mole´ culaire, 24
Avenue des Maquis du Gre´ sivaudan, BP 87,
38702 La Tronche Cedex, France
2 Fax ⁄ Tel: + 33 4 76 63 68 79
E-mail: [email protected]
*Present address
De´partement de kine´ siologie, Universite´ de
Montre´ al, Canada
(Received 5 July 2007, revised 10 August
2007, accepted 14 August 2007)
doi:10.1111/j.1742-4658.2007.06044.x
Pyruvate is located at a crucial crossroad of cellular metabolism between
the aerobic and anaerobic pathways. Modulation of the fate of pyruvate,
in one direction or another, can be important for adaptative response to
hypoxia followed by reoxygenation. This could alter functioning of the
antioxidant system and have protective effects against DNA damage
induced by such stress. Transient hypoxia and alterations of pyruvate
metabolism are observed in tumors. This could be advantageous for cancer
cells in such stressful conditions. However, the effect of pyruvate in tumor
cells is poorly documented during hypoxia ⁄reoxygenation. In this study, we
showed that cells had a greater need for pyruvate during hypoxia. Pyruvate
decreased the number of DNA breaks, and might favor DNA repair. We
demonstrated that pyruvate was a precursor for the biosynthesis of glutathione through oxidative metabolism in HepG2 cells. Therefore, glutathione decreased during hypoxia, but was restored after reoxygenation.
Pyruvate had beneficial effects on glutathione depletion and DNA breaks
induced after reoxygenation. Our results provide more evidence that the
a-keto acid promotes the adaptive response to hypoxia followed by reoxygenation. Pyruvate might thus help to protect cancer cells under such
stressful conditions, which might be harmful for patients with tumors.
Abbreviations
GSH(c-glutamyl), c-glutamyl glutathione; HIF-1, hypoxia-inducible factor; PCA, perchloric acid; ROS, reactive oxygen species.
15188 FEBS Journal 274 (2007) 5188–5198 Journal compilation ª 2007 FEBS. No claim to original French government works